Your browser doesn't support javascript.
loading
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Fehrenbacher, Louis; Cecchini, Reena S; Geyer, Charles E; Rastogi, Priya; Costantino, Joseph P; Atkins, James N; Crown, John P; Polikoff, Jonathan; Boileau, Jean-Francois; Provencher, Louise; Stokoe, Christopher; Moore, Timothy D; Robidoux, André; Flynn, Patrick J; Borges, Virginia F; Albain, Kathy S; Swain, Sandra M; Paik, Soonmyung; Mamounas, Eleftherios P; Wolmark, Norman.
Affiliation
  • Fehrenbacher L; NRG Oncology, Pittsburgh, PA.
  • Cecchini RS; Kaiser Permanente Oncology Clinical Trials Northern CA, Novato, CA.
  • Geyer CE; NRG Oncology, Pittsburgh, PA.
  • Rastogi P; University of Pittsburgh, Pittsburgh, PA.
  • Costantino JP; NRG Oncology, Pittsburgh, PA.
  • Atkins JN; Houston Methodist Cancer Center, Houston, TX.
  • Crown JP; NRG Oncology, Pittsburgh, PA.
  • Polikoff J; University of Pittsburgh Cancer Institute, Pittsburgh, PA.
  • Boileau JF; NRG Oncology, Pittsburgh, PA.
  • Provencher L; University of Pittsburgh, Pittsburgh, PA.
  • Stokoe C; NRG Oncology, Pittsburgh, PA.
  • Moore TD; Southeast Clinical Oncology Research-National Cancer Institute Community Oncology Research Program, Richmond, VA.
  • Robidoux A; NRG Oncology, Pittsburgh, PA.
  • Flynn PJ; Irish Cooperative Oncology Research Group/Cancer Trials Ireland, Dublin, Ireland.
  • Borges VF; St Vincent's University Hospital, Dublin, Ireland.
  • Albain KS; NRG Oncology, Pittsburgh, PA.
  • Swain SM; Kaiser Permanente Southern California, San Diego, CA.
  • Paik S; NRG Oncology, Pittsburgh, PA.
  • Mamounas EP; McGill University, Montréal, Québec, Canada.
  • Wolmark N; NRG Oncology, Pittsburgh, PA.
J Clin Oncol ; 38(5): 444-453, 2020 02 10.
Article in En | MEDLINE | ID: mdl-31821109

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Type: Article Affiliation country: Panama

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Type: Article Affiliation country: Panama